James Zarley, a Texas Roadhouse Inc. (TXRH) insider since 2004, filed a Form 4 disclosing the purchase of 18,900 shares of TXRH on May 1 at $52.91. The long-time director's $992K purchase was a reversal -- Zarley sold 10,900 shares of the steakhouse chain in February of...
Somewhere, Benjamin Graham is smiling. The father of Value Investing and mentor to Warren Buffett had a favorite investment strategy: Buying “Net-Net” stocks. These are stocks that because of bad markets, bad business, bad luck – or a combination of all three -- are trading for less than the net cash they have in the bank.
On Dec. 23, Nierenberg Investment filed a 13D/A on Houston Wire and Cable (HWCC). The investment adviser expressed frustration that the market value of its long-held position in the micro-cap has "widened substantially over the last two years." The filing amended a 13D...
When the equities in your portfolio plummet, you may find yourself asking: What are these stocks really worth? They’ve fallen ten or twenty percent – what’s to keep them from declining even further? Well here’s one thing that can anchor a portfolio: Sizeable dividend payments.
The stock market's rally since the March 23 low has been stunning. The S&P 500 is up nearly 30% from those levels as of yesterday's close. So it's not surprising that insider selling has accelerated into the rally. Insiders were big net buyers...
In the investing world, those with superior information usually make the most money. And possibly no group has better information on public companies – and profitably acts on it – than corporate insiders at small-cap biotech and medical technology companies.
General Electric (GE), once the bluest of blue-chip stocks, has fallen hard. Since the end of 2016, GE’s market cap has dropped by 70% -- from $277 billion to $83 billion. In June GE was dropped from the Dow Jones Industrial Average after more than a century. The stock now trades at $9.30, down nearly 50% year-to date.
Select Medical Insider buying has been historically rare. And It's been nearly a decade since Rocco Ortenzio purchased stock of Select Medical Holdings (SEM). But in a Form 4 filed on March 18, the Vice-Chairman and Co-Founder of the hospital operator disclosed a buy...
If you’re an officer or director of a public company, this is your worst nightmare: You’re sipping coffee at work one morning when a FedEx package is dropped on your desk. Inside you find a letter from the SEC notifying you of a court date to answer charges of trading on inside information. A scenario to be avoided for sure. However, here’s the problem:  The U.S. has no insider trading laws. What? I can hear you saying, then how is it that white collar criminals do time for profiting from secret information? Good question.
Continuing the series on the greatest insider trades: On October 15, 2018, Citigroup (NYSE:C) reported Q3 2018 EPS of $1.73 on revenues of $18.39B, generally in line with expectations. Trading near $70, Citi has a market cap of $175 billion, and is one of the premiere U.S. financial institutions.